v3.26.1
10-Q Acquisitions - Schedule of deferred consideration liability (Details) - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended 12 Months Ended
Apr. 14, 2025
Oct. 04, 2024
Jan. 31, 2026
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Business Combination, Contingent Consideration, Liability [Roll Forward]                
Total deferred consideration liability, beginning balance     $ 2,966 $ 2,966 $ 35,068 $ 35,068 $ 43,652  
Deferred consideration recognized on acquisition           920 1,218  
Accretion of interest on deferred consideration       146   2,436    
Effect of exchange rate differences       (16)   63 82  
Change in fair value on deferred consideration paid           (46) (796)  
Issuance of SVS as settlements of deferred consideration           (77)    
Post-closing purchase price adjustment       (182)     (3,740)  
Cash payments of deferred consideration       (618)   (35,398) (11,250)  
Total deferred consideration liability, ending balance       2,296   2,966 35,068 $ 43,652
Deferred consideration, total       2,296   2,966 35,068 43,652
Less: Deferred consideration liability - current       (2,171)   (2,966) (33,068)  
Deferred consideration liability - net of current       125   0 2,000  
Payments of deferred consideration       618 3,000 35,398 11,250 27,358 [1]
Tryke                
Business Combination, Contingent Consideration, Liability [Roll Forward]                
Total deferred consideration liability, beginning balance     0 0 32,564 32,564 41,652  
Deferred consideration recognized on acquisition           0 0  
Accretion of interest on deferred consideration       0   2,436    
Effect of exchange rate differences       0   0 0  
Change in fair value on deferred consideration paid           0 0  
Issuance of SVS as settlements of deferred consideration           0    
Post-closing purchase price adjustment   $ 3,700   0     (3,740)  
Cash payments of deferred consideration       0   (35,000) (11,250)  
Total deferred consideration liability, ending balance       0   0 32,564 41,652
Deferred consideration, total       0   0 32,564 41,652
Less: Deferred consideration liability - current       0   0    
Deferred consideration liability - net of current       0   0    
NRPC                
Business Combination, Contingent Consideration, Liability [Roll Forward]                
Total deferred consideration liability, beginning balance     2,000 2,000 2,000 2,000 2,000  
Deferred consideration recognized on acquisition           0 0  
Accretion of interest on deferred consideration       0   0    
Effect of exchange rate differences       0   0 0  
Change in fair value on deferred consideration paid           0 0  
Issuance of SVS as settlements of deferred consideration           0    
Post-closing purchase price adjustment       (182)     0  
Cash payments of deferred consideration       (618)   0 0  
Total deferred consideration liability, ending balance     1,200 1,200   2,000 2,000 2,000
Deferred consideration, total     1,200 1,200   2,000 2,000 2,000
Less: Deferred consideration liability - current       (1,075)   (2,000)    
Deferred consideration liability - net of current       125   0    
Deferred consideration, amount retained for tax     2,000          
Curaleaf Poland S.A.                
Business Combination, Contingent Consideration, Liability [Roll Forward]                
Total deferred consideration liability, beginning balance     0 0 504 504 0  
Deferred consideration recognized on acquisition           0 1,218  
Accretion of interest on deferred consideration       0   0    
Effect of exchange rate differences       0   17 82  
Change in fair value on deferred consideration paid           (46) (796)  
Issuance of SVS as settlements of deferred consideration           (77)    
Post-closing purchase price adjustment       0     0  
Cash payments of deferred consideration       0   (398) 0  
Total deferred consideration liability, ending balance       0   0 504 0
Deferred consideration, total       0   0 504 0
Less: Deferred consideration liability - current       0   0    
Deferred consideration liability - net of current       0   0    
Payments of deferred consideration $ 400              
Acquisition related deferred equity consideration (in shares) 32,017              
Other                
Business Combination, Contingent Consideration, Liability [Roll Forward]                
Total deferred consideration liability, beginning balance     $ 966 966 $ 0 0 0  
Deferred consideration recognized on acquisition           920 0  
Accretion of interest on deferred consideration       146   0    
Effect of exchange rate differences       (16)   46 0  
Change in fair value on deferred consideration paid           0 0  
Issuance of SVS as settlements of deferred consideration           0    
Post-closing purchase price adjustment       0     0  
Cash payments of deferred consideration       0   0 0  
Total deferred consideration liability, ending balance       1,096   966 0 0
Deferred consideration, total       1,096   966 $ 0 $ 0
Less: Deferred consideration liability - current       (1,096)   (966)    
Deferred consideration liability - net of current       $ 0   $ 0    
[1]
(1) Amounts reported in the Company’s Annual Financial Statements for the years ended December 31, 2023 have been recast to reflect reclassification of Missouri and Hemp-derived THC operations as discontinued operations.